Journal
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
Volume 13, Issue 3, Pages 474-487Publisher
SPRINGERNATURE
DOI: 10.1039/c3pp50333j
Keywords
-
Funding
- scientific committee of the European Society for Photobiology (ESP)
- Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0661.09, G.0728.10, G.0584.12N]
- KU Leuven [GOA/11/009, PDMK/12/146]
- FWO postdoctoral fellowship
- Inter-university Attraction Poles Programme
Ask authors/readers for more resources
Tumours are a form of pseudo-organs with their own microenvironment where the cancer cells nurture a dysfunctional immune environment incapable of inciting anti-tumour immunity. It had been proposed that the only way to counteract such an immune system dysfunction in tumours is by eliciting, therapeutically, a cancer cell death pathway that is accompanied by high immunogenicity and possibly inhibits or reduces the influence of the pro-tumourigenic cytokine signalling. Subsequently, a small and a large-scale screening study as well as several targeted studies found that few, selected anticancer therapeutic regimens are able to induce a promising kind of cancer cell demise called immunogenic cell death (ICD), which can activate the immune system owing to the spatiotemporally defined emission of danger signals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available